Cooper Companies, Inc.
6140 Stoneridge Mall Road
Suite 590
Pleasanton
California
94588
United States
Tel: 925-460-3600
Fax: 925-460-3662
Website: http://www.coopercos.com/
103 articles about Cooper Companies, Inc.
-
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
1/6/2022
CooperCompanies, will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022.
-
CooperCompanies Completes Acquisition of Generate Life Sciences®
12/17/2021
CooperCompanies announced it has completed the previously announced definitive purchase agreement to acquire Generate Life Sciences, a leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage, for a purchase price of approximately $1.6 billion.
-
CooperCompanies Declares Cash Dividend - Dec 08, 2021
12/8/2021
CooperCompanies announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 9, 2022, to stockholders of record on January 21, 2022.
-
CooperCompanies Announces Fourth Quarter and Full Year 2021 Results
12/2/2021
CooperCompanies announced financial results for its fiscal fourth quarter and full year ended October 31, 2021.
-
CooperCompanies Announces Executive Management Changes
11/18/2021
CooperCompanies announced two senior leadership changes that will enable the company to maximize current and future opportunities.
-
Generate Life Sciences to be acquired by CooperCompanies
11/10/2021
Generate Life Sciences® announces it has entered into an agreement to be acquired by the publicly held healthcare company, CooperCompanies and become part of CooperSurgical, a recognized global leader in women's health and fertility solutions.
-
CooperCompanies to Acquire Generate Life Sciences® for $1.6 Billion
11/10/2021
CooperCompanies announced that it has signed a definitive purchase agreement to acquire Generate Life Sciences, a privately held leading provider of donor egg and sperm for fertility treatments, fertility cryopreservation services and newborn stem cell storage.
-
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2021
11/2/2021
CooperCompanies, announced it will release fourth quarter and full year 2021 financial results on Thursday, December 2, 2021, at 4:15 PM ET.
-
CooperCompanies Announces Third Quarter 2021 Results
9/2/2021
CooperCompanies announced financial results for its fiscal third quarter ended July 31, 2021.
-
CooperCompanies Announces MiSight® Approval in China
8/12/2021
CooperCompanies, announced that the Chinese National Medical Products Administration, which regulates medical devices and pharmaceuticals in China, has approved CooperVision MiSight® 1 day contact lenses for use within the country following a priority review.
-
CooperCompanies Announces Release Date for Third Quarter 2021
7/29/2021
CooperCompanies, announced it will release third quarter 2021 financial results on Thursday, September 2, 2021, at 4:15 PM ET.
-
CooperCompanies Declares Cash Dividend - July 14, 2021
7/14/2021
CooperCompanies, announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 11, 2021, to stockholders of record on July 27, 2021.
-
CooperCompanies Announces Second Quarter 2021 Results
6/3/2021
CooperCompanies announced financial results for its fiscal second quarter ended April 30, 2021.
-
CooperCompanies Elects Maria Rivas, MD to Board of Directors
5/12/2021
CooperCompanies announced that its Board of Directors has elected Dr. Maria Rivas as an independent director, effective July 1, 2021.
-
CooperCompanies Announces Release Date for Second Quarter 2021
4/29/2021
CooperCompanies, announced it will release second quarter 2021 financial results on Thursday, June 3, 2021, at 4:15 PM ET.
-
CooperCompanies Announces New Board AppointmentsRobert S. Weiss named Chairman of the Board and William A. Kozy named Vice Chairman and Lead Director
3/24/2021
CooperCompanies announced that its Board of Directors elected Robert S. Weiss as Chairman of the Board and William A. Kozy as Vice Chairman and Lead Director. Both appointments are effective March 23, 2021.
-
CooperCompanies Announces First Quarter 2021 Results
3/4/2021
CooperCompanies announced financial results for its fiscal first quarter ended January 31, 2021.
-
CooperCompanies to Participate in the KeyBanc Life Sciences MedTech Investor Forum
3/2/2021
CooperCompanies, will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021.
-
CooperCompanies Acquires Safe Obstetric Systems
3/1/2021
CooperCompanies, announced that CooperSurgical has acquired Safe Obstetric Systems, a privately held manufacturer of the medical device, Fetal Pillow®.
-
CooperCompanies to Participate in the Oppenheimer Annual Healthcare Conference - Feb 18, 2021
2/18/2021
CooperCompanies, will participate in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021.